XTL Biopharmaceuticals Ltd. Cash Conversion Cycle 2011-2026 | XTLB

Annual Cash Conversion Cycle XTL Biopharmaceuticals Ltd.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	-	-9.73	-303	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-9.73	-303	-157

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Heron Therapeutics HRTX	751	$ 0.8	2.7 %	$ 133 M	USA
Amphastar Pharmaceuticals AMPH	205	$ 19.23	-1.38 %	$ 899 M	USA
Altimmune ALT	7.85 K	$ 3.44	2.99 %	$ 303 M	USA
Aytu BioScience AYTU	174	$ 2.63	0.77 %	$ 16.5 M	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Incyte Corporation INCY	-54.7	$ 90.45	-0.36 %	$ 17.7 B	USA
Inovio Pharmaceuticals INO	1.91 K	$ 1.61	1.9 %	$ 35.7 M	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-8.96 K	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
BioDelivery Sciences International BDSI	340	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Kamada Ltd. KMDA	163	$ 8.2	-0.61 %	$ 260 M	Israel
Calithera Biosciences CALA	28.8	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Karyopharm Therapeutics KPTI	72.5	$ 6.66	-12.71 %	$ 812 K	USA
Keros Therapeutics KROS	4.72	$ 11.24	2.55 %	$ 418 M	USA
Clovis Oncology CLVS	65.5	-	-7.23 %	$ 13 M	USA
Longeveron LGVN	-212	$ 0.95	-2.71 %	$ 16.7 B	USA
Denali Therapeutics DNLI	1.89	$ 21.09	4.56 %	$ 3.47 B	USA
Arbutus Biopharma Corporation ABUS	31.5	$ 4.42	4.25 %	$ 734 M	Canada